ArticlePloS one2024

Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study.

Nadia Gul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.